Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer

被引：1

作者：

Liu, Jiaming ^{[1
]}

Yao, Lu ^{[1
]}

Sun, Jie ^{[1
]}

Hu, Li ^{[1
]}

Chen, Jiuan ^{[1
]}

Zhang, Juan ^{[1
]}

Xu, Ye ^{[1
]}

Xie, Yuntao ^{[1
]}

机构：

[1] Peking Univ, Canc Hosp & Inst, Familial & Hereditary Canc Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

来源：

CANCER BIOLOGY & MEDICINE | 2023年 / 20卷 / 02期

基金：

中国国家自然科学基金;

关键词：

BRCA1; variant; BRCA2; cancer risk in relatives; Chinese breast cancer patients; family history of cancer; GERMLINE MUTATIONS; BRCA2; MUTATIONS; CHINESE WOMEN; COHORT;

D O I：

10.20892/j.issn.2095-3941.2022.0593

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objective: The spectrum and risk of cancer in relatives of BRCA1/2 pathogenic variant carriers in the Chinese population have not been established.Methods: A family history of cancer in 9903 unselected breast cancer patients was retrospectively analyzed. BRCA1/2 status was determined for all patients and relative risks (RRs) were calculated to evaluate cancer risk in relatives of the patients.Results: The incidences of breast cancer in female relatives of BRCA1 carriers, BRCA2 carriers, and non-carriers were 33.0%, 32.2%, and 7.7%, respectively. The corresponding incidences of ovarian cancer were 11.5%, 2.4%, and 0.5%, respectively. The incidences of pancreatic cancer in male relatives of BRCA1 carriers, BRCA2 carriers, and non-carriers were 1.4%, 2.7%, and 0.6%, respectively. The corresponding incidences of prostate cancer were 1.0%, 2.1%, and 0.4%, respectively. The risks of breast and ovarian cancers in female relatives of BRCA1 and BRCA2 carriers were significantly higher than female relatives of non-carriers (BRCA1: RR = 4.29, P < 0.001 and RR = 21.95, P < 0.001; BRCA2: RR = 4.19, P < 0.001 and RR = 4.65, P < 0.001, respectively). Additionally, higher risks of pancreatic and prostate cancers were noted in male relatives of BRCA2 carriers than non-carriers (RR = 4.34, P = 0.001 and RR = 4.86, P = 0.001, respectively). Conclusions: Female relatives of BRCA1 and BRCA2 carriers are at increased risk for breast and ovarian cancers, and male relatives of BRCA2 carriers are at increased risk for pancreatic and prostate cancers.

引用

页码：147 / 154

页数：8

共 30 条

[11] Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants [J].

Li, Shuai ;

Silvestri, Valentina ;

Leslie, Goska ;

Rebbeck, Timothy R. ;

Neuhausen, Susan L. ;

Hopper, John L. ;

Nielsen, Henriette Roed ;

Lee, Andrew ;

Yang, Xin ;

McGuffog, Lesley ;

Parsons, Michael T. ;

Andrulis, Irene L. ;

Arnold, Norbert ;

Belotti, Muriel ;

Borg, Ake ;

Buecher, Bruno ;

Buys, Saundra S. ;

Caputo, Sandrine M. ;

Chung, Wendy K. ;

Colas, Chrystelle ;

Colonna, Sarah, V ;

Cook, Jackie ;

Daly, Mary B. ;

de la Hoya, Miguel ;

de Pauw, Antoine ;

Delhomelle, Helene ;

Eason, Jacqueline ;

Engel, Christoph ;

Evans, D. Gareth ;

Faust, Ulrike ;

Fehm, Tanja N. ;

Fostira, Florentia ;

Fountzilas, George ;

Frone, Megan ;

Garcia-Barberan, Vanesa ;

Garre, Pilar ;

Gauthier-Villars, Marion ;

Gehrig, Andrea ;

Glendon, Gord ;

Goldgar, David E. ;

Golmard, Lisa ;

Greene, Mark H. ;

Hahnen, Eric ;

Hamann, Ute ;

Hanson, Helen ;

Hassan, Tiara ;

Hentschel, Julia ;

Horvath, Judit ;

Izatt, Louise ;

Janavicius, Ramunas .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) :1529-+

[12] The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality:: two recurrent mutations were identified [J].

Li, Wen-Feng ;

Hu, Zhen ;

Rao, Nan-Yan ;

Song, Chuang-Gui ;

Zhang, Bin ;

Cao, Ming-Zhi ;

Su, Feng-Xi ;

Wang, Yong-Sheng ;

He, Ping-Qing ;

Di, Gen-Hong ;

Shen, Kun-Wei ;

Wu, Jiong ;

Lu, Jin-Song ;

Luo, Jian-Min ;

Liu, Xiao-Yi ;

Zhou, Jie ;

Wang, Lei ;

Zhao, Lin ;

Liu, Yan-Bing ;

Yuan, Wen-Tao ;

Yang, Lin ;

Shen, Zhen-Zhou ;

Huang, Wei ;

Shao, Zhi-Ming .

BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (01) :99-109

[13] Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian [J].

Mersch, Jacqueline ;

Jackson, Michelle A. ;

Park, Minjeong ;

Nebgen, Denise ;

Peterson, Susan K. ;

Singletary, Claire ;

Arun, Banu K. ;

Litton, Jennifer K. .

CANCER, 2015, 121 (02) :269-275

[14] Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants [J].

Momozawa, Yukihide ;

Sasai, Rumi ;

Usui, Yoshiaki ;

Shiraishi, Kouya ;

Iwasaki, Yusuke ;

Taniyama, Yukari ;

Parsons, Michael T. ;

Mizukami, Keijiro ;

Sekine, Yuya ;

Hirata, Makoto ;

Kamatani, Yoichiro ;

Endo, Mikiko ;

Inai, Chihiro ;

Takata, Sadaaki ;

Ito, Hidemi ;

Kohno, Takashi ;

Matsuda, Koichi ;

Nakamura, Seigo ;

Sugano, Kokichi ;

Yoshida, Teruhiko ;

Nakagawa, Hidewaki ;

Matsuo, Keitaro ;

Murakami, Yoshinori ;

Spurdle, Amanda B. ;

Kubo, Michiaki .

JAMA ONCOLOGY, 2022, 8 (06) :871-878

[15] Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations [J].

Moran, A. ;

O'Hara, C. ;

Khan, S. ;

Shack, L. ;

Woodward, E. ;

Maher, E. R. ;

Lalloo, F. ;

Evans, D. G. R. .

FAMILIAL CANCER, 2012, 11 (02) :235-242

[16] Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study [J].

Nyberg, Tommy ;

Frost, Debra ;

Barrowdale, Daniel ;

Evans, D. Gareth ;

Bancroft, Elizabeth ;

Adlard, Julian ;

Ahmed, Munaza ;

Barwell, Julian ;

Brady, Angela F. ;

Brewer, Carole ;

Cook, Jackie ;

Davidson, Rosemarie ;

Donaldson, Alan ;

Eason, Jacqueline ;

Gregory, Helen ;

Henderson, Alex ;

Izatt, Louise ;

Kennedy, M. John ;

Miller, Claire ;

Morrison, Patrick J. ;

Murray, Alex ;

Ong, Kai-Ren ;

Porteous, Mary ;

Pottinger, Caroline ;

Rogers, Mark T. ;

Side, Lucy ;

Snape, Katie ;

Walker, Lisa ;

Tischkowitz, Marc ;

Eeles, Rosalind ;

Easton, Douglas F. ;

Antoniou, Antonis C. .

EUROPEAN UROLOGY, 2020, 77 (01) :24-35

[17] The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis [J].

Oh, Mok ;

Alkhushaym, Nasser ;

Fallatah, Saad ;

Althagafi, Abdulhamid ;

Aljadeed, Rana ;

Alsowaida, Yazed ;

Jeter, Joanne ;

Martin, Jennifer R. ;

Babiker, Hani M. ;

McBride, Ali ;

Abraham, Ivo .

PROSTATE, 2019, 79 (08) :880-895

[18] BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis [J].

Oh, Mok ;

McBride, Ali ;

Yun, Seongseok ;

Bhattacharjee, Sandipan ;

Slack, Marion ;

Martin, Jennifer R. ;

Jeter, Joanne ;

Abraham, Ivo .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (11)

[19] Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study [J].

Phelan, C. M. ;

Iqbal, J. ;

Lynch, H. T. ;

Lubinski, J. ;

Gronwald, J. ;

Moller, P. ;

Ghadirian, P. ;

Foulkes, W. D. ;

Armel, S. ;

Eisen, A. ;

Neuhausen, S. L. ;

Senter, L. ;

Singer, C. F. ;

Ainsworth, P. ;

Kim-Sing, C. ;

Tung, N. ;

Llacuachaqui, M. ;

Chornokur, G. ;

Ping, S. ;

Narod, S. A. .

BRITISH JOURNAL OF CANCER, 2014, 110 (02) :530-534

[20] Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada [J].

Risch, Harvey A. ;

McLaughlin, John R. ;

Cole, David E. C. ;

Rosen, Barry ;

Bradley, Linda ;

Fan, Isabel ;

Tang, James ;

Li, Song ;

Zhang, Shiyu ;

Shaw, Patricia A. ;

Narod, Steven A. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (23) :1694-1706

← 1 2 3 →